MHB039A
MHB039A is a bispecific antibody from Minghui Pharmaceutical (Hangzhou) Ltd, in registered phase 2 trials for metastatic cancer.
Overview
MHB039A is listed on ClinicalTrials.gov as an intervention in 4 registered phase 2 trials sponsored by Minghui Pharmaceutical (Hangzhou) Ltd, in metastatic cancer. A bispecific antibody, as described in the registry record: one molecule binds two different targets, most often a tumour antigen and an immune cell or a second tumour pathway. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A bispecific antibody, as described in the registry record: one molecule binds two different targets, most often a tumour antigen and an immune cell or a second tumour pathway.
1.One arm of MHB039A binds its target on the cancer cell.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"MHB039A" OR ABSTRACT:"MHB039A") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about MHB039A, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentMHB036C
Shares A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors, A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer, Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentEVM14
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentHST-1011
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentIPG1094
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentSelicrelumab
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentCamonsertib
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentEvexomostat
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentMerestinib
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.